Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
AMWL American Well	$7.90 -2.4%	$9.93	$5.00 ▼ $17.17	$123.30M	1.18	102,342 shs	48,341 shs
DGX Quest Diagnostics	$167.28 +0.8%	$166.64	$125.42 ▼ $178.87	$18.56B	0.92	917,142 shs	1.14 million shs
HIMS Hims & Hers Health	$29.11 -8.8%	$39.88	$11.20 ▼ $72.98	$6.47B	1.37	14.29 million shs	20.87 million shs
LFMD LifeMD	$5.45 -2.7%	$5.83	$3.99 ▼ $12.88	$242.98M	1.5	805,553 shs	731,121 shs
LH Laboratory Co. of America	$229.75 -0.8%	$244.80	$191.97 ▼ $258.59	$19.23B	1.12	620,812 shs	479,830 shs
LLY Eli Lilly and Company	$820.30 -0.2%	$844.31	$711.40 ▼ $972.53	$777.78B	0.34	3.31 million shs	2.12 million shs
MED Medifast	$13.82 -1.4%	$14.85	$13.48 ▼ $38.56	$151.16M	1.13	328,236 shs	137,715 shs
NVO Novo Nordisk A/S	$69.36 -1.1%	$82.33	$69.11 ▼ $148.15	$311.23B	0.42	5.56 million shs	5.85 million shs
TDOC Teladoc Health	$8.12 -5.2%	$10.34	$6.76 ▼ $15.27	$1.41B	1.27	6.19 million shs	4.32 million shs
WW WW International	$0.50 -7.3%	$0.76	$0.38 ▼ $2.35	$40.03M	1.83	4.54 million shs	1.15 million shs

12 Stocks Corporate Insiders are Abandoning

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
AMWL American Well	+1.93%	+3.19%	-22.11%	+3.65%	-53.31%
DGX Quest Diagnostics	-0.32%	-0.07%	-5.44%	+8.84%	+26.76%
HIMS Hims & Hers Health	-4.31%	-2.73%	-20.00%	+20.32%	+103.09%
LFMD LifeMD	-6.20%	-0.88%	+12.68%	+7.28%	-44.99%
LH Laboratory Co. of America	-0.64%	-1.68%	-8.47%	+0.53%	+6.96%
LLY Eli Lilly and Company	-0.57%	-2.51%	-8.90%	+4.98%	+5.58%
MED Medifast	+2.34%	-2.88%	-2.82%	-20.63%	-62.80%
NVO Novo Nordisk A/S	-2.18%	-10.87%	-22.83%	-19.68%	-45.19%
TDOC Teladoc Health	-1.19%	+4.65%	-23.58%	-9.58%	-44.04%
WW WW International	+5.11%	-9.78%	-18.35%	-57.89%	-70.38%

Remove Ads

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
AMWL American Well	3.0649 of 5 stars	3.1	4.0	0.0	0.0	2.2	2.5	1.3
DGX Quest Diagnostics	4.8751 of 5 stars	2.3	3.0	4.2	4.7	3.9	2.5	2.5
HIMS Hims & Hers Health	3.2659 of 5 stars	3.1	2.0	0.0	0.0	2.8	3.3	1.9
LFMD LifeMD	1.9056 of 5 stars	3.5	1.0	0.0	0.0	2.0	1.7	0.6
LH Laboratory Co. of America	4.7654 of 5 stars	3.4	3.0	2.5	4.2	3.6	2.5	1.3
LLY Eli Lilly and Company	4.8251 of 5 stars	2.4	5.0	3.3	4.0	3.4	2.5	1.9
MED Medifast	3.7169 of 5 stars	2.0	3.0	0.0	2.0	2.8	1.7	2.5
NVO Novo Nordisk A/S	4.8113 of 5 stars	4.4	5.0	1.7	0.0	2.4	0.0	4.4
TDOC Teladoc Health	3.1878 of 5 stars	4.2	2.0	0.0	0.0	1.4	2.5	1.3
WW WW International	1.8218 of 5 stars	3.1	3.0	0.0	0.0	2.1	1.7	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
AMWL American Well	2.17	Hold	$11.90	50.65% Upside
DGX Quest Diagnostics	2.67	Moderate Buy	$178.38	6.64% Upside
HIMS Hims & Hers Health	2.27	Hold	$37.31	28.18% Upside
LFMD LifeMD	3.00	Buy	$11.43	109.70% Upside
LH Laboratory Co. of America	2.86	Moderate Buy	$269.92	17.48% Upside
LLY Eli Lilly and Company	2.85	Moderate Buy	$1,009.72	23.09% Upside
MED Medifast	2.00	Hold	$16.50	19.39% Upside
NVO Novo Nordisk A/S	2.80	Moderate Buy	$145.25	109.43% Upside
TDOC Teladoc Health	2.39	Hold	$11.26	38.81% Upside
WW WW International	2.20	Hold	$3.00	500.48% Upside

Current Analyst Ratings Breakdown

Latest LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
3/20/2025	DGX Quest Diagnostics	Robert W. Baird Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Outperform ➝ Outperform	$190.00 ➝ $191.00
3/18/2025	HIMS Hims & Hers Health	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Underperform ➝ Underperform	$21.00 ➝ $22.00
3/13/2025	NVO Novo Nordisk A/S	Kepler Capital Markets Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy
3/12/2025	LFMD LifeMD	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$12.00 ➝ $14.00
3/11/2025	LFMD LifeMD	B. Riley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
3/11/2025	LFMD LifeMD	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$15.00 ➝ $15.00
3/6/2025	LLY Eli Lilly and Company	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target		$1,146.00
3/6/2025	HIMS Hims & Hers Health	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Underperform ➝ Underperform	$21.00 ➝ $21.00
3/6/2025	HIMS Hims & Hers Health	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sell ➝ Sell	$27.00 ➝ $27.00
3/5/2025	LLY Eli Lilly and Company	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$970.00 ➝ $1,100.00
3/4/2025	DGX Quest Diagnostics	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$185.00 ➝ $185.00

(Data available from 3/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
AMWL American Well	$254.36M	0.48	N/A	N/A	$20.31 per share	0.39
DGX Quest Diagnostics	$9.87B	1.88	$13.05 per share	12.82	$61.04 per share	2.74
HIMS Hims & Hers Health	$1.48B	4.38	N/A	N/A	$1.61 per share	18.08
LFMD LifeMD	$212.45M	1.14	N/A	N/A	$0.15 per share	36.33
LH Laboratory Co. of America	$13.01B	1.48	$20.72 per share	11.09	$96.27 per share	2.39
LLY Eli Lilly and Company	$45.04B	17.27	$13.37 per share	61.34	$15.05 per share	54.50
MED Medifast	$602.46M	0.25	$2.83 per share	4.88	$19.21 per share	0.72
NVO Novo Nordisk A/S	$290.40B	1.07	$3.22 per share	21.57	$4.64 per share	14.95
TDOC Teladoc Health	$2.57B	0.55	$0.52 per share	15.64	$14.05 per share	0.58
WW WW International	$785.92M	0.05	$0.42 per share	1.18	($9.62) per share	-0.05

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
AMWL American Well	-$208.14M	-$14.00	N/A	N/A	N/A	-81.83%	-56.73%	-42.15%	4/29/2025 (Estimated)
DGX Quest Diagnostics	$871M	$7.69	21.75	15.95	2.16	8.80%	15.07%	6.72%	4/22/2025 (Estimated)
HIMS Hims & Hers Health	-$23.55M	$0.54	66.15	55.97	N/A	8.19%	10.97%	8.29%	5/5/2025 (Estimated)
LFMD LifeMD	-$20.60M	-$0.54	N/A	45.42	N/A	-12.06%	N/A	-36.34%	5/6/2025 (Estimated)
LH Laboratory Co. of America	$746M	$8.82	26.05	13.10	1.71	5.73%	15.29%	7.01%	4/24/2025 (Estimated)
LLY Eli Lilly and Company	$10.59B	$11.71	70.05	26.36	1.40	23.51%	85.24%	16.19%	5/1/2025 (Estimated)
MED Medifast	$99.42M	$0.18	76.78	9.03	N/A	0.35%	10.64%	7.57%	4/28/2025 (Estimated)
NVO Novo Nordisk A/S	$14.64B	$3.29	21.08	14.88	0.90	34.81%	84.68%	26.29%	5/1/2025 (Estimated)
TDOC Teladoc Health	-$220.37M	-$5.88	N/A	N/A	N/A	-37.91%	-10.06%	-4.86%	4/24/2025 (Estimated)
WW WW International	-$112.25M	-$4.37	N/A	N/A	N/A	-56.84%	N/A	-0.32%	5/1/2025 (Estimated)

Latest LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
4/24/2025	N/A	LH Laboratory Co. of America	$3.75	N/A	N/A	N/A	$3.41 billion	N/A
4/24/2025	N/A	TDOC Teladoc Health	-$0.32	N/A	N/A	N/A	$619.38 million	N/A
4/22/2025	N/A	DGX Quest Diagnostics	$2.18	N/A	N/A	N/A	$2.63 billion	N/A
3/10/2025	Q4 2024	LFMD LifeMD	-$0.04	-$0.02	+$0.02	-$0.02	$57.43 million	$64.26 million
2/27/2025	Q4 2024	WW WW International	$0.01	$0.32	+$0.31	$0.31	$173.23 million	$184.41 million
2/26/2025	Q4 2024	TDOC Teladoc Health	-$0.21	-$0.28	-$0.07	-$0.28	$639.44 million	$640.49 million
2/24/2025	Q4 2024	HIMS Hims & Hers Health	$0.09	$0.11	+$0.02	$0.11	$494.56 million	$481.14 million
2/18/2025	Q4 2024	MED Medifast	-$0.16	$0.10	+$0.26	$0.08	$114.25 million	$119.00 million
2/12/2025	Q4 2024	AMWL American Well	-$3.04	-$2.77	+$0.27	-$2.77	$66.57 million	N/A
2/6/2025	Q4 2024	LH Laboratory Co. of America	$3.40	$3.45	+$0.05	$1.70	$3.31 billion	N/A
2/6/2025	Q4 2024	LLY Eli Lilly and Company	$5.45	$5.32	-$0.13	$4.88	$13.42 billion	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
AMWL American Well	N/A	N/A	N/A	N/A	N/A
DGX Quest Diagnostics	$3.20	1.91%	+6.94%	41.61%	14 Years
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
LFMD LifeMD	N/A	N/A	N/A	N/A	N/A
LH Laboratory Co. of America	$2.88	1.25%	N/A	32.65%	N/A
LLY Eli Lilly and Company	$6.00	0.73%	+15.21%	51.24%	11 Years
MED Medifast	$6.60	47.76%	N/A	3,666.67%	N/A
NVO Novo Nordisk A/S	$1.57	2.26%	+25.26%	47.72%	N/A
TDOC Teladoc Health	N/A	N/A	N/A	N/A	N/A
WW WW International	N/A	N/A	N/A	N/A	N/A

Latest LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
1/30/2025	DGX Quest Diagnostics	quarterly	$0.80	2.06%	4/7/2025	4/7/2025	4/21/2025
2/5/2025	NVO Novo Nordisk A/S	semi-annual	$0.7874	1.2%	3/31/2025	3/31/2025	4/8/2025
1/8/2025	LH Laboratory Co. of America	quarterly	$0.72	1.23%	2/27/2025	2/27/2025	3/12/2025

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
AMWL American Well	N/A	2.85	2.82
DGX Quest Diagnostics	0.82	1.10	1.02
HIMS Hims & Hers Health	N/A	2.14	1.82
LFMD LifeMD	N/A	0.83	0.78
LH Laboratory Co. of America	0.67	1.44	1.30
LLY Eli Lilly and Company	2.00	1.15	0.97
MED Medifast	N/A	3.34	2.55
NVO Novo Nordisk A/S	0.62	0.74	0.55
TDOC Teladoc Health	0.66	1.73	1.69
WW WW International	N/A	0.53	0.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
AMWL American Well	56.05%
DGX Quest Diagnostics	88.06%
HIMS Hims & Hers Health	63.52%
LFMD LifeMD	35.52%
LH Laboratory Co. of America	95.94%
LLY Eli Lilly and Company	82.53%
MED Medifast	95.51%
NVO Novo Nordisk A/S	11.54%
TDOC Teladoc Health	76.82%
WW WW International	86.18%

Insider Ownership

Company	Insider Ownership
AMWL American Well	12.80%
DGX Quest Diagnostics	0.79%
HIMS Hims & Hers Health	17.71%
LFMD LifeMD	15.97%
LH Laboratory Co. of America	0.85%
LLY Eli Lilly and Company	0.13%
MED Medifast	2.50%
NVO Novo Nordisk A/S	0.07%
TDOC Teladoc Health	0.95%
WW WW International	8.12%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
AMWL American Well	1,040	15.61 million	13.61 million	Optionable
DGX Quest Diagnostics	48,000	110.98 million	110.73 million	Optionable
HIMS Hims & Hers Health	650	222.17 million	179.79 million	Optionable
LFMD LifeMD	230	44.58 million	36.40 million	Optionable
LH Laboratory Co. of America	75,500	83.70 million	82.93 million	Optionable
LLY Eli Lilly and Company	39,000	948.17 million	948.08 million	Optionable
MED Medifast	870	10.94 million	10.67 million	Optionable
NVO Novo Nordisk A/S	54,400	4.49 billion	4.48 billion	Optionable
TDOC Teladoc Health	5,100	173.67 million	170.53 million	Optionable
WW WW International	4,850	80.13 million	73.38 million	Optionable

LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Headlines

Recent News About These Companies

Best Health & Fitness Stocks to Buy for Strong Growth

March 24, 2025 | zacks.com

‘Snow White’ Bashful With $87.3M Global Bow; ‘Captain America: Brave New World’ Crosses $400M WW – International Box Office

March 23, 2025 | msn.com

Short Interest in WW International, Inc. (NASDAQ:WW) Expands By 23.6%

March 19, 2025 | americanbankingnews.com

WeightWatchers, Lenders Start Private Talks to Address Debt

March 18, 2025 | bloomberg.com

‘Ne Zha 2’ Overtakes ‘Star Wars: The Force Awakens’ To Become No. 5 Highest-Grossing Movie Ever WW – International Box Office

March 16, 2025 | msn.com

WW International Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags

March 3, 2025 | finance.yahoo.com

WeightWatchers' debt burden, GLP-1 shortage spooks investors

March 1, 2025 | msn.com

WW International (NASDAQ:WW) Announces Quarterly Earnings Results

February 28, 2025 | marketbeat.com

WW International (NASDAQ:WW) Releases Quarterly Earnings Results, Beats Estimates By $0.31 EPS

February 28, 2025 | marketbeat.com

Q4 2024 WW International Inc Earnings Call

February 28, 2025 | finance.yahoo.com

WeightWatchers Stock Soars On Q4 Earnings Beat, New CEO Confirmation: Retail Sentiment Jumps

February 28, 2025 | msn.com

WW International Inc.: WW International, Inc. Announces Fourth Quarter and Full Year 2024 Results

February 28, 2025 | finanznachrichten.de

WW International's Interim CEO Gets Job on Permanent Basis, Swings to 4Q Profit

February 27, 2025 | marketwatch.com

WW International, Inc. (WW) Q4 2024 Earnings Call Transcript

February 27, 2025 | seekingalpha.com

WW International (WW) Q4 Earnings and Revenues Beat Estimates

February 27, 2025 | zacks.com

WW International Clinical growth compensates for waning popularity of traditional weight loss program

February 27, 2025 | msn.com

WW International, Inc. Announces Fourth Quarter and Full Year 2024 Results

February 27, 2025 | globenewswire.com

WW International (WW) Gets a Hold from Craig-Hallum

February 24, 2025 | markets.businessinsider.com

WW International, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call

February 24, 2025 | gurufocus.com

WW International, Inc. to Announce Fourth Quarter and Full Year 2024 Results on February 27, 2025

February 24, 2025 | quiverquant.com

WW International, Inc. Schedules Fourth Quarter and Full Year 2024 Earnings Conference Call

February 24, 2025 | investing.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
By Jeffrey Neal Johnson | March 21, 2025
View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?
Intel Foundry’s Moment of Truth: Will 18A Deliver?
By Jeffrey Neal Johnson | March 6, 2025
View Intel Foundry’s Moment of Truth: Will 18A Deliver?
Missed the Hims & Hers Rally? Clover Health Could Be Next
By Gabriel Osorio-Mazilli | March 5, 2025
View Missed the Hims & Hers Rally? Clover Health Could Be Next
These S&P 500 Stocks Have Low P/E Ratios — Time to Buy?
By Sarah Horvath | March 3, 2025
View These S&P 500 Stocks Have Low P/E Ratios — Time to Buy?
2 Catalysts That Could Push NVIDIA Stock Up 30% This Year
By Thomas Hughes | February 27, 2025
View 2 Catalysts That Could Push NVIDIA Stock Up 30% This Year

LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Company Descriptions

American Well NYSE:AMWL

$7.90 -0.19 (-2.36%)

Closing price 03:59 PM Eastern

Extended Trading

$7.85 -0.05 (-0.62%)

As of 04:10 PM Eastern

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members. It provides Carepoint devices comprising carts, peripherals, tablets, and TVs, which serve as digital access points in clinical settings. In addition, the company offers Amwell Medical Group network services consisting of primary and urgent care, behavioral health therapy, acute psychiatry, lactation counseling, and nutrition services. Further, it provides professional services to facilitate implementation, workflow design, systems integration, and service expansion for its products, as well as patient and provider engagement services. The company sells its products through field sales professionals, channel partners, and value-added resellers. American Well Corporation was incorporated in 2006 and is headquartered in Boston, Massachusetts.

Quest Diagnostics NYSE:DGX

$167.28 +1.28 (+0.77%)

Closing price 03:59 PM Eastern

Extended Trading

$166.88 -0.40 (-0.24%)

As of 07:41 PM Eastern

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Hims & Hers Health NYSE:HIMS

$29.10 -2.82 (-8.82%)

Closing price 03:59 PM Eastern

Extended Trading

$28.97 -0.14 (-0.46%)

As of 07:59 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

LifeMD NASDAQ:LFMD

$5.45 -0.15 (-2.68%)

Closing price 04:00 PM Eastern

Extended Trading

$5.47 +0.02 (+0.37%)

As of 07:12 PM Eastern

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more. In addition, the company offers PDFSimpli, an online software as a service platform that allows users to create, edit, convert, sign, and share PDF documents; ResumeBuild which provides digital resume and cover letter services; SignSimpli, a digital signature platform; and LegalSimpli, a provider of legal forms for consumers and small businesses. It sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was incorporated in 1994 and is headquartered in New York, New York.

Laboratory Co. of America NYSE:LH

$229.75 -1.92 (-0.83%)

Closing price 03:59 PM Eastern

Extended Trading

$230.06 +0.31 (+0.13%)

As of 05:31 PM Eastern

Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.

Eli Lilly and Company NYSE:LLY

$820.30 -1.37 (-0.17%)

Closing price 03:59 PM Eastern

Extended Trading

$815.45 -4.85 (-0.59%)

As of 07:57 PM Eastern

Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. The company offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; Jardiance, Mounjaro, and Trulicity for type 2 diabetes; and Zepbound for obesity. It also provides oncology products, including Alimta, Cyramza, Erbitux, Jaypirca, Retevmo, Tyvyt, and Verzenio. In addition, the company offers Olumiant for rheumatoid arthritis, atopic dermatitis, severe alopecia areata, and COVID-19; Taltz for plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, and non-radiographic axial spondylarthritis; Omvoh for ulcerative colitis; Cymbalta for depressive disorder, diabetic peripheral neuropathic pain, generalized anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; Ebglyss for severe atopic dermatitis; and Emgality for migraine prevention and episodic cluster headache. Further, it provides Cialis for erectile dysfunction and benign prostatic hyperplasia; and Forteo for osteoporosis. It has collaborations with Incyte Corporation; Boehringer Ingelheim Pharmaceuticals, Inc.; F. Hoffmann-La Roche Ltd and Genentech, Inc.; Biologics, Inc., AbCellera Biologics Inc.; and Chugai Pharmaceutical Co., Ltd. The company was founded in 1876 and is headquartered in Indianapolis, Indiana.

Medifast NYSE:MED

$13.82 -0.19 (-1.36%)

Closing price 03:59 PM Eastern

Extended Trading

$13.84 +0.02 (+0.14%)

As of 06:48 PM Eastern

Medifast, Inc., through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names. The company markets its products through point-of-sale transactions, as well as through ecommerce platform. Medifast, Inc. was founded in 1980 and is headquartered in Baltimore, Maryland.

Novo Nordisk A/S NYSE:NVO

$69.36 -0.81 (-1.15%)

Closing price 03:59 PM Eastern

Extended Trading

$69.36 +0.01 (+0.01%)

As of 07:59 PM Eastern

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Teladoc Health NYSE:TDOC

$8.12 -0.45 (-5.20%)

Closing price 03:59 PM Eastern

Extended Trading

$8.07 -0.04 (-0.51%)

As of 07:59 PM Eastern

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

WW International NASDAQ:WW

$0.50 -0.04 (-7.31%)

Closing price 04:00 PM Eastern

Extended Trading

$0.50 +0.00 (+0.88%)

As of 07:48 PM Eastern

WW International, Inc. provides weight management products and services worldwide. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. The company also provides various digital subscription products to wellness and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and web-based platform; and allows members to inspire and support each other by sharing their experiences with other people on weight health journeys. In addition, it licenses its trademarks and other intellectual property in food, beverages, and other relevant consumer products and services, as well as provides publishing services. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1961 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare MarketRank™

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Earnings

Compare Dividends

Latest LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

LFMD, TDOC, AMWL, NVO, LLY, LH, DGX, HIMS, WW, and MED Company Descriptions

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools